Cargando…
Dose Consideration of Lenvatinib’s Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine Therapy
SIMPLE SUMMARY: The long-term benefits of lenvatinib on the treatment of advanced hepatocellular carcinoma (HCC) are still unsatisfactory. The search for a new drug to promote lenvatinib’s anti-cancer effect is an urgent issue. Whether the response of HCC to lenvatinib is dose-dependent also still n...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605131/ https://www.ncbi.nlm.nih.gov/pubmed/37894463 http://dx.doi.org/10.3390/cancers15205097 |